4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0001181431-13-036315
CIK 0001114220operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:01 PM ET
Size
6.7 KB
Accession
0001181431-13-036315
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Award
Common Stock
2013-06-19+15,000→ 130,000 total - Award
Stock Options (right to buy)
2013-06-19+25,000→ 25,000 totalExercise: $8.24From: 2014-06-19Exp: 2023-06-19→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]One-third of the shares of common stock vest on each of: 06/19/2014; 06/19/2015; and 06/19/2016.
- [F2]Of the 130,000 shares, 35,000 are restricted common stock.
- [F3]One-third of the options vest on each of: 06/19/2014; 06/19/2015; and 06/19/2016.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:01 PM ET
- Size
- 6.7 KB